Logo image of OVXA.I

OVOCA BIO PLC (OVXA.I) Stock Fundamental Analysis

Europe - Euronext Dublin - DUB:OVXA - IE00B4XVDC01 - Common Stock

0.0105 EUR
0 (-8.7%)
Last: 4/30/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, OVXA scores 2 out of 10 in our fundamental rating. OVXA was compared to 55 industry peers in the Pharmaceuticals industry. OVXA has a great financial health rating, but its profitability evaluates not so good. OVXA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • OVXA had negative earnings in the past year.
  • In the past year OVXA had a positive cash flow from operations.
  • In the past 5 years OVXA always reported negative net income.
  • OVXA had negative operating cash flow in 4 of the past 5 years.
OVXA.I Yearly Net Income VS EBIT VS OCF VS FCFOVXA.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M

1.2 Ratios

  • With a Return On Assets value of -151.63%, OVXA is not doing good in the industry: 88.46% of the companies in the same industry are doing better.
  • OVXA has a Return On Equity of -210.00%. This is amonst the worse of the industry: OVXA underperforms 80.77% of its industry peers.
Industry RankSector Rank
ROA -151.63%
ROE -210%
ROIC N/A
ROA(3y)-77.44%
ROA(5y)-50.21%
ROE(3y)-100.76%
ROE(5y)-64.38%
ROIC(3y)N/A
ROIC(5y)N/A
OVXA.I Yearly ROA, ROE, ROICOVXA.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OVXA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OVXA.I Yearly Profit, Operating, Gross MarginsOVXA.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

7

2. Health

2.1 Basic Checks

  • The number of shares outstanding for OVXA has been increased compared to 1 year ago.
  • There is no outstanding debt for OVXA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OVXA.I Yearly Shares OutstandingOVXA.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
OVXA.I Yearly Total Debt VS Total AssetsOVXA.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

  • OVXA has an Altman-Z score of -5.71. This is a bad value and indicates that OVXA is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -5.71, OVXA is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • OVXA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -5.71
ROIC/WACCN/A
WACCN/A
OVXA.I Yearly LT Debt VS Equity VS FCFOVXA.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • OVXA has a Current Ratio of 6.86. This indicates that OVXA is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of OVXA (6.86) is better than 100.00% of its industry peers.
  • A Quick Ratio of 6.86 indicates that OVXA has no problem at all paying its short term obligations.
  • OVXA has a Quick ratio of 6.86. This is amongst the best in the industry. OVXA outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.86
Quick Ratio 6.86
OVXA.I Yearly Current Assets VS Current LiabilitesOVXA.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 9.01% over the past year.
EPS 1Y (TTM)9.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • OVXA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OVXA.I Price Earnings VS Forward Price EarningsOVXA.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • OVXA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OVXA is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.3
EV/EBITDA N/A
OVXA.I Per share dataOVXA.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for OVXA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OVOCA BIO PLC / OVXA.I FAQ

Can you provide the ChartMill fundamental rating for OVOCA BIO PLC?

ChartMill assigns a fundamental rating of 2 / 10 to OVXA.I.


What is the valuation status of OVOCA BIO PLC (OVXA.I) stock?

ChartMill assigns a valuation rating of 2 / 10 to OVOCA BIO PLC (OVXA.I). This can be considered as Overvalued.


Can you provide the profitability details for OVOCA BIO PLC?

OVOCA BIO PLC (OVXA.I) has a profitability rating of 0 / 10.


Can you provide the financial health for OVXA stock?

The financial health rating of OVOCA BIO PLC (OVXA.I) is 7 / 10.